Venkataraman G - Search Results

1

Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia.

Saygin C, Giordano G, Shimamoto K, Eisfelder B, Thomas-Toth A, Venkataraman G, Ananthanarayanan V, Vincent TL, DuVall A, Patel AA, Chen Y, Tan F, Anthony SP, Chen Y, Shen Y, Odenike O, Teachey DT, Kee BL, LaBelle J, Stock W. Saygin C, et al. Among authors: venkataraman g. Clin Cancer Res. 2023 Aug 15;29(16):3151-3161. doi: 10.1158/1078-0432.CCR-23-0415. Clin Cancer Res. 2023. PMID: 37363966 Free PMC article.

2

Demystifying "exact" logistic regression for pathologists.

Venkataraman G, Ananthanarayanan V. Venkataraman G, et al. J Clin Pathol. 2008 Feb;61(2):237-8. doi: 10.1136/jcp.2007.048769. J Clin Pathol. 2008. PMID: 18223098 No abstract available.

3

Primary benign vascular tumors and tumorlike lesions of the kidney: a clinicopathologic analysis of 15 cases.

Mehta V, Ananthanarayanan V, Antic T, Krausz T, Milner J, Venkataraman G, Picken MM. Mehta V, et al. Among authors: venkataraman g. Virchows Arch. 2012 Dec;461(6):669-76. doi: 10.1007/s00428-012-1333-9. Epub 2012 Oct 23. Virchows Arch. 2012. PMID: 23090628

4

Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal Hematopoiesis.

Saygin C, Zhang P, Stauber J, Aldoss I, Sperling AS, Weeks LD, Luskin MR, Knepper TC, Wanjari P, Wang P, Lager AM, Fitzpatrick C, Segal JP, Gharghabi M, Gurbuxani S, Venkataraman G, Cheng JX, Eisfelder BJ, Bohorquez O, Patel AA, Umesh Nagalakshmi S, Jayaram S, Odenike OM, Larson RA, Godley LA, Arber DA, Gibson CJ, Munshi NC, Marcucci G, Ebert BL, Greally JM, Steidl U, Lapalombella R, Shah BD, Stock W. Saygin C, et al. Among authors: venkataraman g. Blood Cancer Discov. 2024 May 1;5(3):164-179. doi: 10.1158/2643-3230.BCD-23-0106. Blood Cancer Discov. 2024. PMID: 38150184

5

Accessible calculation of multirater kappa statistics for pathologists.

Venkataraman G, Ananthanarayanan V, Paner GP. Venkataraman G, et al. Virchows Arch. 2006 Aug;449(2):272. doi: 10.1007/s00428-006-0209-2. Epub 2006 May 4. Virchows Arch. 2006. PMID: 16673120 No abstract available.

6

Morphometric sum optical density as a surrogate marker for ploidy status in prostate cancer: an analysis in 180 biopsies using logistic regression and binary recursive partitioning.

Venkataraman G, Ananthanarayanan V, Paner GP, He R, Masoom S, Sinacore J, Flanigan RC, Wojcik EM. Venkataraman G, et al. Virchows Arch. 2006 Sep;449(3):302-7. doi: 10.1007/s00428-006-0237-y. Epub 2006 Aug 3. Virchows Arch. 2006. PMID: 16896895

7

Utility of prostate biopsy morphometric sum optical density for identifying extraprostatic extension on subsequent prostatectomy.

Bargaje A, Venkataraman G, Flanigan R, Wojcik EM, Ananthanarayanan V. Bargaje A, et al. Among authors: venkataraman g. Anal Quant Cytol Histol. 2006 Dec;28(6):343-5. Anal Quant Cytol Histol. 2006. PMID: 17220151 No abstract available.

8

Identification of patients with low-risk for aneuploidy: comparative discriminatory models using linear and machine-learning classifiers in prostate cancer.

Venkataraman G, Heinze G, Holmes EW, Ananthanarayanan V, Bostwick DG, Paner GP, Bradford-De La garza CM, Brown HG, Flanigan RC, Wojcik EM. Venkataraman G, et al. Prostate. 2007 Oct 1;67(14):1524-36. doi: 10.1002/pros.20629. Prostate. 2007. PMID: 17683063

9

Morphometric signature differences in nuclei of Gleason pattern 4 areas in Gleason 7 prostate cancer with differing primary grades on needle biopsy.

Venkataraman G, Rycyna K, Rabanser A, Heinze G, Baesens BM, Ananthanarayanan V, Paner GP, Barkan GA, Flanigan RC, Wojcik EM. Venkataraman G, et al. J Urol. 2009 Jan;181(1):88-93; discussion 93-4. doi: 10.1016/j.juro.2008.09.013. Epub 2008 Nov 13. J Urol. 2009. PMID: 19012924

10

Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL.

Sharma S, Galanina N, Guo A, Lee J, Kadri S, Van Slambrouck C, Long B, Wang W, Ming M, Furtado LV, Segal JP, Stock W, Venkataraman G, Tang WJ, Lu P, Wang YL. Sharma S, et al. Among authors: venkataraman g. Oncotarget. 2016 Oct 18;7(42):68833-68841. doi: 10.18632/oncotarget.11932. Oncotarget. 2016. PMID: 27626698 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

279 results

Search Page